Abstract

Researchers are trying to find an alternative to the conventional methods of treatment for various pain associated ailments. Patients prefer pain killer as an immediate solution which is proven to have adverse reactions. Since vibroacoustic sound therapy has shown to have relieving effect on different forms of pain, the goal of the study was to find impact of the same using β-endorphin as biomarker, as this could be non-invasive protocol for dental pain management in the future. As a pilot project, 9 subjects of 20-40 years, clinically diagnosed with acute pulpal pain were considered and exposed to 3 frequency groups (low, moderate and high). Impact of vibroacoustic therapy was clinically evaluated by analyzing human salivary β-endorphin using Elisa kit and pain rated by the patients through a numeric rating scale. Statistical analysis performed showed that there is no significant difference for the entire population (P=0.0526), in (P= 0.3618, 0.8264, 0.0671) and between (P=0.4637) the study groups. It would be misleading to take inference due to the small sample size and other observations made.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.